Drug company exec: ‘We’re hated’ for a reason

Published



SAN FRANCISCO – For a moment at the biggest biotech conference of the year, drug companies found themselves lambasted by one of their own.

“We’ve done all these great things, yet we’re hated,” Regeneron CEO Leonard Schleifer said during his presentation at the JPMorgan Healthcare Investor Conference. “We talk about doing things right, but I’m going to tell you I don’t think we do.”

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.